22 May 2013
Keywords: Isis Pharma, GlaxoSmithKline, ISI-TTR Rx, USA, FDA, Fas t rack, FAB, Polyneuropathy
Article | 14 December 2012
In what has been a busy newsflow few days for USA-based Isis Pharmaceutical (Nasdaq: ISIS), the company said yesterday ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 December 2012
6 November 2012
10 December 2012
21 May 2013
© 2013 thepharmaletter.com